Medicinal Products

Dáil Éireann Debate, Wednesday - 17 December 2025

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Wednesday, 17 December 2025

Ceisteanna (431)

Pádraig Rice

Ceist:

431. Deputy Pádraig Rice asked the Minister for Health to address the issue of access to oral immunotherapy for children with nut allergies; for an update in respect of the HSE senior leadership team’s decision on the medicine in question; and if she will make a statement on the matter. [73118/25]

Freagraí scríofa

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile